Extended interval dosing of natalizumab: is efficacy preserved?

被引:0
|
作者
Clerico, M. [1 ]
Signori, A. [2 ]
De Mercanti, S. [1 ]
Cordioli, C. [3 ]
Signoriello, E. [4 ]
Lus, G. [4 ]
Maniscalco, G. T. [5 ,6 ]
Curti, E. [7 ]
Lorefice, L. [8 ]
Cocco, E. [8 ]
Nociti, V. [9 ]
Mirabella, M. [9 ]
Baroncini, D. [10 ]
Landi, D. [11 ]
Mataluni, G. [11 ]
Petruzzo, M. [12 ]
Lanzillo, R. [12 ]
Gandoglia, I. [13 ]
Laroni, A. [13 ]
Frangiamore, R. [14 ]
Sartori, A. [15 ]
Cavalla, P. [16 ]
Costantini, G. [16 ]
Sormani, M. P. [2 ]
Capra, R. [3 ]
机构
[1] Univ Torino, San Luigi Gonzaga Hosp, Neurol Unit, Clin & Biol Sci Dept, Orbassano, Italy
[2] Univ Genoa, Sect Biostat, Dept Hlth Sci, Genoa, Italy
[3] Spedali Civili Brescia, Multiple Sclerosis Ctr, Presidio Montichiari, Brescia, Italy
[4] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy
[5] AORN A Cardarelli, Neurol Clin, Naples, Italy
[6] AORN A Cardarelli, Multiple Sclerosis Ctr, Naples, Italy
[7] Univ Parma, Dept Med & Surg, Neurol Associates Unit, Parma, Italy
[8] Univ Cagliari, Binaghi Hosp, Dept Med Sci & Publ Hlth, Multiple Sclerosis Ctr, Cagliari, Italy
[9] Fdn Policlin Univ Gemelli, Neurosci Area, Neurosci Aging Head & Neck & Orthopaed Sci Dept, Multiple Sclerosis Ctr, Rome, Italy
[10] ASST Valle Olona, Presidio Osped Gallarate, Ctr Sclerosi Multipla, Gallarate, Italy
[11] Policlin Tor Vergata, UOSD Ctr Riferimento Reg Sclerosi Multipla, Dipartimento Neurosci, Rome, Italy
[12] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Multiple Sclerosis Ctr, Naples, Italy
[13] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[14] IRCCS Fdn, Dept Neuroimmunol & Neuromuscular Dis, Neurol Inst C Besta, Milan, Italy
[15] Azienda Osped Univ Osped Riuniti, Azienda Sanit Univ Integrata Clin Neurol, Neurol Unit, Trieste, Italy
[16] Torino Univ Hosp, Dept Neurosci, Citta Salute & Sci, Turin, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P587
引用
收藏
页码:282 / 283
页数:2
相关论文
共 50 条
  • [1] Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
    Clerico, Marinella
    De Mercanti, Stefania Federica
    Signori, Alessio
    Iudicello, Marco
    Cordioli, Cinzia
    Signoriello, Elisabetta
    Lus, Giacomo
    Bonavita, Simona
    Lavorgna, Luigi
    Maniscalco, Giorgia Teresa
    Curti, Erica
    Lorefice, Lorena
    Cocco, Eleonora
    Nociti, Viviana
    Mirabella, Massimiliano
    Baroncini, Damiano
    Mataluni, Giorgia
    Landi, Doriana
    Petruzzo, Martina
    Lanzillo, Roberta
    Gandoglia, Ilaria
    Laroni, Alice
    Frangiamore, Rita
    Sartori, Arianna
    Cavalla, Paola
    Costantini, Gianfranco
    Sormani, Maria Pia
    Capra, Ruggero
    NEUROTHERAPEUTICS, 2020, 17 (01) : 200 - 207
  • [2] Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
    Marinella Clerico
    Stefania Federica De Mercanti
    Alessio Signori
    Marco Iudicello
    Cinzia Cordioli
    Elisabetta Signoriello
    Giacomo Lus
    Simona Bonavita
    Luigi Lavorgna
    Giorgia Teresa Maniscalco
    Erica Curti
    Lorena Lorefice
    Eleonora Cocco
    Viviana Nociti
    Massimiliano Mirabella
    Damiano Baroncini
    Giorgia Mataluni
    Doriana Landi
    Martina Petruzzo
    Roberta Lanzillo
    Ilaria Gandoglia
    Alice Laroni
    Rita Frangiamore
    Arianna Sartori
    Paola Cavalla
    Gianfranco Costantini
    Maria Pia Sormani
    Ruggero Capra
    Neurotherapeutics, 2020, 17 : 200 - 207
  • [3] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, M.
    Ayyoubi, N.
    Tamim, H.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 871
  • [4] Efficacy and safety of natalizumab extended interval dosing
    Yamout, Bassem, I
    Sahraian, Mohamad Ali
    El Ayoubi, Nabil
    Tamim, Hani
    Nicolas, Johnny
    Khoury, Samia J.
    Zeineddine, Maya M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 24 : 113 - 116
  • [5] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, Maya
    Ayyoubi, Nabil
    Tamim, Hani
    Nicolas, Johny
    Khoury, Samia
    Yamout, Bassem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP22 - NP23
  • [6] Effectiveness of Natalizumab in Extended Dosing Interval
    Hervas, Jose Vicente
    Punet-Ortiz, Joan
    Teniente-Serra, Aina
    Mansilla, M. Jos
    Quirant-Sanchez, Bibiana
    Navarro, Juan
    Presas, Silvia
    Martinez-Caceres, Eva
    Ramo, Cristina
    NEUROLOGY, 2016, 86
  • [7] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [8] Extended-interval dosing of natalizumab in NOVA
    Stuve, Olaf
    Tugemann, Bastian
    LANCET NEUROLOGY, 2023, 22 (03): : 199 - 200
  • [9] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
  • [10] Extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Frohman, T. C.
    Foley, J.
    Kister, I.
    Weinstock-Guttman, B.
    Tornatore, C.
    Pandey, K.
    Donnelly, S.
    Pawate, S.
    Bomprezzi, R.
    Smith, D.
    Kolb, C.
    Qureshi, S.
    Okuda, D.
    Kalina, J.
    Rimler, Z.
    Green, R.
    Monson, N.
    Hoyt, T.
    Bradshaw, M.
    Fallon, J.
    Chamot, E.
    Bucello, M.
    Beh, S.
    Cutter, G.
    Major, E.
    Herbert, J.
    Frohman, E. M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (08): : 885 - 889